Advertisement

Diagnostics and Differential Diagnostics of Spinal Cord Tumors

  • Zulejha Merhemic
  • Majda M. Thurnher
Chapter

Abstract

Spinal cord tumors are rare tumors with nonspecific clinical symptoms, usually occurring in the late stage of the disease resulting in delayed diagnosis. Radicular symptoms and other symptoms such as back pain, slowly progressive neurologic deficits, or skeletal deformities, such as kyphoscoliosis, are commonly observed in children. Spinal cord tumors amount to between 20 and 30% of all primary intradural spinal tumors. About 70–80% of the remaining primary intradural tumors are located in the intradural-extramedullary compartment.

Keywords

Tumors Intraspinal Diagnostic Intraspinal Diagnostic MRI 

References

  1. 1.
    Duong LM, McCarthy BJ, McLendon RE, Dolecek TA, Kruchko C, Douglas LL, Ajani UA. Descriptive epidemiology of malignant and nonmalignant primary spinal cord, spinal meninges, and cauda equina tumors, United States, 2004-2007. Cancer. 2012;118(17):4220–7.  https://doi.org/10.1002/cncr.27390.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Landi A, Palmarini V, D'Elia A, Marotta N, Salvati M, Santoro A, Delfini R. Magnetic resonance diffusion tensor imaging and fiber-tracking diffusion tensor tractography in the management of spinal astrocytomas. World J Clin Cases. 2016;4(1):1–4.  https://doi.org/10.12998/wjcc.v4.i1.1.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Alkherayf F, Arab AF, Tsai E. Conus medullaris teratoma with utilization of fiber tractography: case report. J Neurol Surg Rep. 2015;76(1):e183–7.  https://doi.org/10.1055/s-0035-1555134.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Setzer M, Murtagh RD, Murtagh FR, Eleraky M, Jain S, Marquardt G, Seifert V, Vrionis FD. Diffusion tensor imaging tractography in patients with intramedullary tumors: comparison with intraoperative findings and value for prediction of tumor resectability. J Neurosurg Spine. 2010;13(3):371–80.  https://doi.org/10.3171/2010.3.SPINE09399.CrossRefPubMedGoogle Scholar
  5. 5.
    Choudhri AF, Whitehead MT, Klimo P Jr, Montgomery BK, Boop FA. Diffusion tensor imaging to guide surgical planning in intramedullary spinal cord tumors in children. Neuroradiology. 2014;56(2):169–74.  https://doi.org/10.1007/s00234-013-1316-9.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Krings T, Lasjaunias PL, Hans FJ, Mull M, Nijenhuis RJ, Alvarez H, Backes WH, Reinges MH, Rodesch G, Gilsbach JM, Thron AK. Imaging in spinal vascular disease. Neuroimaging Clin N Am. 2007;17(1):57–72.  https://doi.org/10.1016/j.nic.2007.01.001.CrossRefPubMedGoogle Scholar
  7. 7.
    Naito K, Yamagata T, Arima H, Abe J, Tsuyuguchi N, Ohata K, Takami T. Qualitative analysis of spinal intramedullary lesions using PET/CT. J Neurosurg Spine. 2015;23:1–7.  https://doi.org/10.3171/2015.2.SPINE141254.CrossRefGoogle Scholar
  8. 8.
    Louis DN, Ohgaki H, Wiestler OD, et al. The WHO classification of tumours of the central nervous system. Revised 4th Edition. Lyon: International Agency for Research on Cancer; 2016.Google Scholar
  9. 9.
    Samartzis D, Gillis CC, Shih P, O'Toole JE, Fessler RG. Intramedullary spinal cord tumors: part I-epidemiology, pathophysiology, and diagnosis. Global Spine J. 2015;5(5):425–35.  https://doi.org/10.1055/s-0035-1549029.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Merhemic Z, Stosic-Opincal T, Thurnher MM. Neuroimaging of spinal tumors. Magn Reson Imaging Clin N Am. 2016;24(3):563–79.  https://doi.org/10.1016/j.mric.2016.04.007.CrossRefPubMedGoogle Scholar
  11. 11.
    Chen X, Li C, Che X, Chen H, Liu Z. Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study. Acta Neurochir. 2016;158(1):101–7.  https://doi.org/10.1007/s00701-015-2637-8.CrossRefPubMedGoogle Scholar
  12. 12.
    Kasper EM, Ippen FM, Maragkos GA, Anderson MP, Rojas R, Mahadevan A. Tanycytic ependymoma of the brain stem, presentations of rare cystic disease variants and review of literature. J Neurosurg Sci. 2018;62(1):78–88.  https://doi.org/10.23736/S0390-5616.17.04194-7.CrossRefPubMedGoogle Scholar
  13. 13.
    Tomek M, Jayajothi A, Brandner S, Jaunmuktane Z, Lee CH, Davagnanam I. Imaging features of spinal tanycytic ependymoma. Neuroradiol J. 2016;29(1):61–5.  https://doi.org/10.1177/1971400915621322.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Oh MC, Tarapore PE, Kim JM, Sun MZ, Safaee M, Kaur G, Aranda DM, Parsa AT. Spinal ependymomas: benefits of extent of resection for different histological grades. J Clin Neurosci. 2013;20(10):1390–7.  https://doi.org/10.1016/j.jocn.2012.12.010.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Khan NR, Vanlandingham M, O'Brien T, Boop FA, Arnautovic K. Primary seeding of Myxopapillary Ependymoma: different disease in adult population? Case report and review of literature. World Neurosurg. 2017;99:812 e821–6.  https://doi.org/10.1016/j.wneu.2016.12.022.CrossRefGoogle Scholar
  16. 16.
    Huisman TA. Pediatric tumors of the spine. Cancer Imaging. 2009;9:S45–8.  https://doi.org/10.1102/1470-7330.2009.9012.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Ruppert B, Welsh CT, Hannah J, Giglio P, Rumboldt Z, Johnson I, Fortney J, Jenrette JM, Patel S, Scheithauer BW. Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neuro-Oncol. 2011;104(2):529–33.  https://doi.org/10.1007/s11060-010-0505-1.CrossRefGoogle Scholar
  18. 18.
    Marko NF, Weil RJ. The molecular biology of WHO grade I astrocytomas. Neuro-Oncology. 2012;14(12):1424–31.  https://doi.org/10.1093/neuonc/nos257.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Yagi T, Ohata K, Haque M, Hakuba A. Intramedullary spinal cord tumour associated with neurofibromatosis type 1. Acta Neurochir. 1997;139(11):1055–60.CrossRefGoogle Scholar
  20. 20.
    Gessi M, Dorner E, Dreschmann V, Antonelli M, Waha A, Giangaspero F, Gnekow A, Pietsch T. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases. Hum Pathol. 2016;49:107–13.  https://doi.org/10.1016/j.humpath.2015.09.041.CrossRefPubMedGoogle Scholar
  21. 21.
    Oppenheimer DC, Johnson MD, Judkins AR. Ganglioglioma of the spinal cord. J Clin Imaging Sci. 2015;5:53.  https://doi.org/10.4103/2156-7514.166355.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Joaquim AF, Ghizoni E, dos Santos MJ, Valadares MG, da Silva FS, Tedeschi H. Intramedullary hemangioblastomas: surgical results in 16 patients. Neurosurg Focus. 2015;39(2):E18.  https://doi.org/10.3171/2015.5.FOCUS15171.CrossRefPubMedGoogle Scholar
  23. 23.
    Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194(3):629–42.  https://doi.org/10.1148/radiology.194.3.7862955.CrossRefPubMedGoogle Scholar
  24. 24.
    Chung SY, Jeun SS, Park JH. Disseminated Hemangioblastoma of the central nervous system without Von Hippel-Lindau disease. Brain Tumor Res Treat. 2014;2(2):96–101.  https://doi.org/10.14791/btrt.2014.2.2.96.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Koda M, Mannoji C, Itabashi T, Kita T, Murakami M, Yamazaki M, Aramomi M, Ikeda O, Furuya T. Intramedullary hemorrhage caused by spinal cord hemangioblastoma: a case report. BMC Res Notes. 2014;7:823.  https://doi.org/10.1186/1756-0500-7-823.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Pojskic M, Arnautovic KI. Microsurgical resection of spinal cord Hemangioblastoma: 2-dimensional operative video. Oper Neurosurg (Hagerstown). 2018;  https://doi.org/10.1093/ons/opy123.CrossRefGoogle Scholar
  27. 27.
    Pojskic M, Arnautovic KI. Microsurgical resection of medulla oblongata Hemangioblastoma: 2-dimensional operative video. Oper Neurosurg (Hagerstown). 2018;  https://doi.org/10.1093/ons/opy074.CrossRefGoogle Scholar
  28. 28.
    Hirano K, Imagama S, Sato K, Kato F, Yukawa Y, Yoshihara H, Kamiya M, Deguchi M, Kanemura T, Matsubara Y, Inoh H, Kawakami N, Takatsu T, Ito Z, Wakao N, Ando K, Tauchi R, Muramoto A, Matsuyama Y, Ishiguro N. Primary spinal cord tumors: review of 678 surgically treated patients in Japan. A multicenter study. Eur Spine J. 2012;21(10):2019–26.  https://doi.org/10.1007/s00586-012-2345-5.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sun I, Pamir MN. Non-syndromic spinal schwannomas: a novel classification. Front Neurol. 2017;8:318.  https://doi.org/10.3389/fneur.2017.00318.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Evans DG. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16.  https://doi.org/10.1186/1750-1172-4-16.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    MacCollin M, Chiocca EA, Evans DG, Friedman JM, Horvitz R, Jaramillo D, Lev M, Mautner VF, Niimura M, Plotkin SR, Sang CN, Stemmer-Rachamimov A, Roach ES. Diagnostic criteria for schwannomatosis. Neurology. 2005;64(11):1838–45.  https://doi.org/10.1212/01.WNL.0000163982.78900.AD.CrossRefGoogle Scholar
  32. 32.
    Fehlings MG, Nater A, Zamorano JJ, Tetreault LA, Varga PP, Gokaslan ZL, Boriani S, Fisher CG, Rhines L, Bettegowda C, Kawahara N, Chou D. Risk factors for recurrence of surgically treated conventional spinal schwannomas: analysis of 169 patients from a multicenter international database. Spine (Phila Pa 1976). 2016;41(5):390–8.  https://doi.org/10.1097/BRS.0000000000001232.CrossRefGoogle Scholar
  33. 33.
    Ando K, Imagama S, Ito Z, Kobayashi K, Yagi H, Hida T, Ito K, Tsushima M, Ishikawa Y, Ishiguro N. How do spinal schwannomas progress? The natural progression of spinal schwannomas on MRI. J Neurosurg Spine. 2016;24(1):155–9.  https://doi.org/10.3171/2015.3.SPINE141218.CrossRefPubMedGoogle Scholar
  34. 34.
    Chen MZ. Neurofibroma. In: Ross J, Brant-Zawadski M, Moore KR, Crim J, Chen MZ, Katzman G, editors. Diagnostic imaging: brain. 1st ed. Salt Lake City: Amirsys; 2004. p. 90–3.Google Scholar
  35. 35.
    D'Amico A, Mazio F, Ugga L, Cuocolo R, Cirillo M, Santoro C, Perrotta S, Melis D, Brunetti A. Medullary unidentified bright objects in Neurofibromatosis type 1: a case series. BMC Pediatr. 2018;18(1):91.  https://doi.org/10.1186/s12887-018-1067-1.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Carman K, Yakut A, Anlar B, Ayter S. Spinal neurofibromatosis associated with classical neurofibromatosis type 1: genetic characterisation of an atypical case. BMJ Case Rep. 2013;2013:bcr2012008468.  https://doi.org/10.1136/bcr-2012-008468.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Kshettry VR, Hsieh JK, Ostrom QT, Kruchko C, Benzel EC, Barnholtz-Sloan JS. Descriptive epidemiology of spinal Meningiomas in the United States. Spine (Phila Pa 1976). 2015;40(15):E886–9.  https://doi.org/10.1097/BRS.0000000000000974.CrossRefGoogle Scholar
  38. 38.
    Arnautovic K, Arnautovic A. Extramedullary intradural spinal tumors: a review of modern diagnostic and treatment options and a report of a series. Bosn J Basic Med Sci. 2009;9(Suppl 1):40–5.  https://doi.org/10.17305/bjbms.2009.2755.CrossRefPubMedGoogle Scholar
  39. 39.
    Bansil R, Walia BS, Khan Z, Abrari A. Metastasis to a spinal meningioma. Surg Neurol Int. 2017;8:102.  https://doi.org/10.4103/sni.sni_466_16.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Takeuchi K, Hagiwara Y, Kanaya K, Wada K, Shiba M, Kato Y. Drop metastasis of adrenocorticotropic hormone-producing pituitary carcinoma to the cauda equina. Asian Spine J. 2014;8(5):680–3.  https://doi.org/10.4184/asj.2014.8.5.680.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Perrin RG, Livingston KE, Aarabi B. Intradural extramedullary spinal metastasis. A report of 10 cases J Neurosurg. 1982;56(6):835–7.  https://doi.org/10.3171/jns.1982.56.6.0835.CrossRefPubMedGoogle Scholar
  42. 42.
    Lee CH, Kim KJ, Hyun SJ, Jahng TA, Kim HJ. Intradural extramedullary metastasis of small cell lung cancer: a case report. Korean J Spine. 2012;9(3):293–6.  https://doi.org/10.14245/kjs.2012.9.3.293.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Abul-Kasim K, Thurnher MM, McKeever P, Sundgren PC. Intradural spinal tumors: current classification and MRI features. Neuroradiology. 2008;50(4):301–14.  https://doi.org/10.1007/s00234-007-0345-7.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Ziu E, Mesfin FB. Cancer, metastasis, spinal. In: StatPearls. Treasure Island (FL); 2018.Google Scholar
  45. 45.
    Rykken JB, Diehn FE, Hunt CH, Eckel LJ, Schwartz KM, Kaufmann TJ, Wald JT, Giannini C, Wood CP. Rim and flame signs: postgadolinium MRI findings specific for non-CNS intramedullary spinal cord metastases. AJNR Am J Neuroradiol. 2013;34(4):908–15.  https://doi.org/10.3174/ajnr.A3292.CrossRefPubMedGoogle Scholar
  46. 46.
    Shah A, Redhu R, Nadkarni T, Goel A. Supratentorial glioblastoma multiforme with spinal metastases. J Craniovertebr Junction Spine. 2010;1(2):126–9.  https://doi.org/10.4103/0974-8237.77678.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Zulejha Merhemic
    • 1
  • Majda M. Thurnher
    • 2
  1. 1.Policlinic Sunce Agram, University of SarajevoSarajevoBosnia and Herzegovina
  2. 2.Department of Biomedical imaging and Image-Guided TherapyMedical University ViennaViennaAustria

Personalised recommendations